ACADIA Pharmaceuticals Inc. logo ACAD - ACADIA Pharmaceuticals Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 0
BUY 26
HOLD 10
SELL 1
STRONG
SELL 0
| PRICE TARGET: $34.78 DETAILS
HIGH: $40.00
LOW: $29.00
MEDIAN: $35.00
CONSENSUS: $34.78
UPSIDE: 64.83%

Profitability Ratios

Ratio Value
GP Margin 91.7%
EBIT Margin 13.0%
EBITDA Margin 13.0%
Operating Margin 9.8%
Pretax Margin 13.0%
Cont. Ops Margin 36.5%
Net Margin 36.5%
Bottom Line Margin 36.5%

Liquidity Ratios

Ratio Value
Current Ratio 3.83
Quick Ratio 3.71
Solvency Ratio 1.161
Cash Ratio 0.64

Valuation Ratios

Ratio Value
Price/Earnings
11.57
Hist. avg: 9.4
Peers avg: 25.0
PEG Ratio 0.17
Forward PEG 0.17
Price/Book 3.69
Price/Sales 4.22
Price/FCF 43.02
Price/Op Cash Flow 41.18

Debt Ratios

Ratio Value
Debt/Assets 0.0334
Debt/Equity 0.0425
Debt/Capital 0.0408
Long-Term Debt/Capital 0.0000
Financial Leverage 1.27

Cash Flow Ratios

Ratio Value
Working Capital Turnover 1.61
Operating Cash Flow Ratio 0.396
Operating Cash Flow/Sales 10.3%
Free Cash Flow/Operating Cash Flow 95.7%

Coverage Ratios

Ratio Value
Debt Service Coverage 33.61
Interest Coverage 0.0000
Short-Term Operating Cash Flow Coverage 9.44
Operating Cash Flow Coverage 2.10
Capital Expenditure Coverage 23.42
Dividend + Capital Expenditure Coverage 23.42

Dividend Ratios

Ratio Value
Payout Ratio 0.0000%
Dividend Yield 0.0000%
Dividend Yield % 0.0000%
Dividend Per Share 0.0000

Per Share Ratios

Ratio Value
Revenue/Share 6.33
EPS 2.309
Debt/Share 0.3082
Cash/Share 4.84
Book Value/Share 7.25
Tangible BV/Share 6.61
Equity/Share 7.25
Operating Cash Flow/Share 0.649
Capital Expenditure/Share 0.028
FCF/Share 0.621

Other Ratios

Ratio Value
Net Income/Earnings Before Tax 2.815
Earnings Before Tax/EBIT 1.325
Price/Fair Value 3.69
Debt/Market Cap 0.0026
Effective Tax Rate -181.5%
Enterprise Value Multiple 31.66